View in EDS PDF Full Text

Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis.

Saved in:
Bibliographic Details
Title: Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis.
Authors: Cheng, Ning1 (AUTHOR) ning.cheng@abbvie.com, Dominguez, Annaliza1 (AUTHOR) annaliza.dominguez@abbvie.com, Manthena, Shivaji R.1 (AUTHOR) Shivaji.Manthena@abbvie.com, Shah, Darshini1 (AUTHOR) darshini2111@gmail.com
Source: Neurology & Therapy. Jun2026, p1-13. 13p.
Database: Academic Search Ultimate
Description
ISSN:21938253
DOI:10.1007/s40120-026-00967-3